SCLC

Clinical trials for SCLC explained in plain language.

Never miss a new study

Get alerted when new SCLC trials appear

Sign up with your email to follow new studies for SCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 11 Not yet recruiting 1 Not yet finished but already full! 7 Completed 1 Terminated 1

Experimental cancer therapy targets tough tumors with radioactive precision

Disease control Terminated

This early-stage trial tested a two-step radioimmunotherapy combining GD2-SADA and 177Lu-DOTA in patients with recurrent or metastatic solid tumors, including small cell lung cancer, high-risk neuroblastoma, sarcoma, and melanoma. The goal was to assess safety and find the right …

Matched conditions: SCLC

Phase: PHASE1 • Sponsor: Y-mAbs Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

SCLC

Get alerted when new SCLC trials appear

Experimental cancer therapy targets tough tumors with radioactive precision